Login / Signup

Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted.

Aditya Kumar PandaSunali PadhiAbhijit PatiTapan Kumar Singh Nayak
Published in: Human cell (2021)
Keyphrases
  • randomized controlled trial
  • sars cov
  • combination therapy
  • study protocol
  • replacement therapy